![]() ![]() Starting with a standard coronary CTA, the HeartFlow Analysis leverages deep learning and highly trained analysts to create a digital, personalized 3D model of the heart. “These new data are a reflection of the company’s commitment to providing comprehensive clinical evidence on the diagnostic accuracy, safety, efficacy and utility of the HeartFlow Analysis to help clinicians engage patients in the decision-making process and confidently diagnose and optimize treatment for patients with coronary artery disease.” ENDS About the HeartFlow FFR CT Analysis “It’s rare to have the opportunity to follow patients for 10 years in clinical trials and we were pleased to confirm the long-term prognostic value of FFR CT through the DISCOVER-FLOW trial,” said Campbell Rogers, MD, FACC, Chief Medical Officer, HeartFlow. All patients received a HeartFlow Analysis following a coronary CT scan. The DISCOVER-FLOW trial was the first-in-human trial evaluating the HeartFlow Analysis and enrolled 103 patients from 4 international hospitals. ![]() “The 10-year outcomes indicate that FFR CT is a more useful non-invasive test than coronary CT alone as the information provided helps physicians with long-term risk stratification and treatment selection for patients with coronary artery disease.” We want to be able to provide immediate symptom relief and have confidence that the treatment we are selecting, specifically the possible benefits of revascularization, will have a positive, long-lasting impact,” said Bon-Kwon Koo, MD, PhD, FACC, Professor of Internal Medicine, Seoul National University, and Director of the Cardiovascular Center and Chair of the Cardiology Division, Seoul National University Hospital. ![]() “When diagnosing and managing patients with coronary artery disease (CAD), physicians want to understand the impact of treatment. The 10-year results from the DISCOVER-FLOW trial were presented as a late-breaking trial during the virtual EuroPCR conference. – May 18, 2021 - HeartFlow, Inc., a leader in revolutionizing precision heartcare, today announced new data which indicate that the information provided by the HeartFlow FFR CT Analysis was a superior predictor of 10-year outcomes compared to the severity of a coronary stenosis shown on a coronary computed tomography angiogram (CTA). ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |